Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    11504744 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Drosophila-generated CTL
Condition: Metastatic Cutaneous Melanoma
Interventions: Drug: fludarabine;   Drug: cyclophosphamide;   Drug: Drosophila-peptide pulsed Melanoma-reactive autologous CD8+ PBL;   Drug: Aldesleukin
2 Recruiting Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Cobimetinib

Study has passed its completion date and status has not been verified in more than two years.